ConductScience.org, home

Paper40132017

Preclinical Profile of CM699 as a Medication Candidate for Stimulant Use Disorder.

Hiranita T and 12 others. ACS Chem Neurosci, 2025. Cited by 1 paper, by iCite.

Cite this record

ConductScience Library. Preclinical Profile of CM699 as a Medication Candidate for Stimulant Use Disorder. Papers, record 40132017. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40132017

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Preclinical Profile of CM699 as a Medication Candidate for Stimulant Use Disorder.
PubMed
Journal
ACS Chem Neurosci
PubMed
Year
2025
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
1
iCite
Revised in PubMed
2025-09-06
PubMed

Authors13

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Hiranita TTakatohttps://orcid.org/0009-0000-2494-2754
2Hong WCWeimin C
3Sharma AAbhisheakhttps://orcid.org/0000-0003-0553-4039
4Lopez JPJessica P
5Mesangeau CChristophe
6Whittaker DADaniel A
7Alsharif WWalidhttps://orcid.org/0000-0001-7513-487X
8Kopajtic TATheresa A
9Jamalapuram SSeshulatha
10Avery BABonnie A
11Tanda GGianluigi
12McCurdy CRChristopher Rhttps://orcid.org/0000-0001-8695-2915
13Katz JLJonathan L

Source PubMed

Download CSV of authors

Topics13

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Receptors, sigmaMajor topic
Central Nervous System StimulantsMajor topic
Substance-Related DisordersMajor topic
Animals
Male
Dopamine Plasma Membrane Transport Proteins
Rats
Rats, Sprague-Dawley
Self Administration
Dopamine
Cocaine
Dopamine Uptake Inhibitors
Nucleus Accumbens

Source PubMed

Download CSV of topics

Grants5

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
R01 DA058018NIDA NIH HHSUnited StatesR01DA058018PubMed and NIHNIH RePORTER
Z01 DA000103Intramural NIH HHSUnited StatesZ01DA000103PubMedNIH RePORTER
R01 DA023205NIDA NIH HHSUnited StatesR01DA023205PubMed and NIHNIH RePORTER
ZIA DA000103Intramural NIH HHSUnited StatesZIADA000103PubMedNIH RePORTER
ZIA DA000611Intramural NIH HHSUnited StatesZIADA000611PubMed and NIHNIH RePORTER

Download CSV of grants

References40

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
137311803Interactions of calmodulin kinase II with the dopamine transporter facilitate cocaine-induced enhancement of evoked dopamine release.Transl Psychiatry2023https://conductscience.org/library/papers/37311803PubMed
221859929Decreases in cocaine self-administration with dual inhibition of the dopamine transporter and σ receptors.J Pharmacol Exp Ther2011https://conductscience.org/library/papers/21859929PubMed
315681658Effects of 4'-chloro-3 alpha-(diphenylmethoxy)-tropane on mesostriatal, mesocortical, and mesolimbic dopamine transmission: comparison with effects of cocaine.J Pharmacol Exp Ther2005https://conductscience.org/library/papers/15681658PubMed
425970245Neurotransmitter and psychostimulant recognition by the dopamine transporter.Nature2015https://conductscience.org/library/papers/25970245PubMed
58378254Physiological parameters in laboratory animals and humans.Pharm Res1993https://conductscience.org/library/papers/8378254PubMed
618363822Cocaine-like neurochemical effects of antihistaminic medications.J Neurochem2008https://conductscience.org/library/papers/18363822PubMed
728495886The sigma-1 receptor modulates dopamine transporter conformation and cocaine binding and may thereby potentiate cocaine self-administration in rats.J Biol Chem2017https://conductscience.org/library/papers/28495886PubMed
81686761Selective sigma ligands block stimulant effects of cocaine.Eur J Pharmacol1991https://conductscience.org/library/papers/1686761PubMed
912490613Sigma1 receptor agonist-mediated regulation of N-methyl-D-aspartate-stimulated [3H]dopamine release is dependent upon protein kinase C.J Pharmacol Exp Ther2003https://conductscience.org/library/papers/12490613PubMed
1023187725Self-administration of cocaine induces dopamine-independent self-administration of sigma agonists.Neuropsychopharmacology2013https://conductscience.org/library/papers/23187725PubMed
118726752Preclinical evaluation of pharmacotherapies for treatment of cocaine and opioid abuse using drug self-administration procedures.Neuropsychopharmacology1996https://conductscience.org/library/papers/8726752PubMed
12245180352-isoxazol-3-phenyltropane derivatives of cocaine: molecular and atypical system effects at the dopamine transporter.J Pharmacol Exp Ther2014https://conductscience.org/library/papers/24518035PubMed
1328110353A Role for Sigma Receptors in Stimulant Self-Administration and Addiction.Handb Exp Pharmacol2017https://conductscience.org/library/papers/28110353PubMed
1420688912Membrane cholesterol modulates the outward facing conformation of the dopamine transporter and alters cocaine binding.J Biol Chem2010https://conductscience.org/library/papers/20688912PubMed
1520950794Sigma receptor agonists: receptor binding and effects on mesolimbic dopamine neurotransmission assessed by microdialysis.Biol Psychiatry2011https://conductscience.org/library/papers/20950794PubMed
167783132Sigma ligands with subnanomolar affinity and preference for the sigma 2 binding site. 2. Spiro-joined benzofuran, isobenzofuran, and benzopyran piperidines.J Med Chem1995https://conductscience.org/library/papers/7783132PubMed
1722112179Targeting sigma receptors: novel medication development for drug abuse and addiction.Expert Rev Clin Pharmacol2009https://conductscience.org/library/papers/22112179PubMed
1829945932Dopamine Transporter Dynamics of N-Substituted Benztropine Analogs with Atypical Behavioral Effects.J Pharmacol Exp Ther2018https://conductscience.org/library/papers/29945932PubMed
198276070Cocaine and several sigma receptor ligands inhibit dopamine uptake in rat caudate-putamen.Eur J Pharmacol1993https://conductscience.org/library/papers/8276070PubMed
2017268407Differential effects of sigma1 receptor blockade on self-administration and conditioned reinstatement motivated by cocaine vs natural reward.Neuropsychopharmacology2007https://conductscience.org/library/papers/17268407PubMed

See all 40 referencesDownload CSV of references

Cited by1

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1 citation.

PMIDTitleJournalYearIn Papers
41092850Dual sigma receptor/dopamine transporter inhibition and the union of pharmacology and experimental psychology.J Pharmacol Exp Ther2025https://conductscience.org/library/papers/41092850

Source PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/40132017

GET https://conductscience.org/api/papers/v1/40132017/references?page=2